291 related articles for article (PubMed ID: 35876094)
21. Hereditary angioedema in childhood: an approach to management.
Ebo DG; Verweij MM; De Knop KJ; Hagendorens MM; Bridts CH; De Clerck LS; Stevens WJ
Paediatr Drugs; 2010 Aug; 12(4):257-68. PubMed ID: 20593909
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: the Italian experience.
Cancian M;
Curr Opin Allergy Clin Immunol; 2015 Aug; 15(4):383-91. PubMed ID: 26106828
[TBL] [Abstract][Full Text] [Related]
23. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema.
Valerieva A; Caccia S; Cicardi M
Expert Rev Clin Immunol; 2018 Sep; 14(9):707-718. PubMed ID: 30021471
[TBL] [Abstract][Full Text] [Related]
24. Icatibant as acute treatment for hereditary angioedema in adults.
Farkas H
Expert Rev Clin Pharmacol; 2016 Jun; 9(6):779-88. PubMed ID: 27123689
[TBL] [Abstract][Full Text] [Related]
25. Current and emerging biologics for the treatment of hereditary angioedema.
Perego F; Wu MA; Valerieva A; Caccia S; Suffritti C; Zanichelli A; Bergamaschini L; Cicardi M
Expert Opin Biol Ther; 2019 Jun; 19(6):517-526. PubMed ID: 30912460
[TBL] [Abstract][Full Text] [Related]
26. Hereditary and acquired angioedema.
Patel G; Pongracic JA
Allergy Asthma Proc; 2019 Nov; 40(6):441-445. PubMed ID: 31690390
[TBL] [Abstract][Full Text] [Related]
27. C1 Inhibitor Activity and Angioedema Attacks in Patients with Hereditary Angioedema.
Kaplan AP; Pawaskar D; Chiao J
J Allergy Clin Immunol Pract; 2020 Mar; 8(3):892-900. PubMed ID: 31655295
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency.
Zanichelli A; Mansi M; Periti G; Cicardi M
Expert Rev Clin Immunol; 2013 May; 9(5):477-88. PubMed ID: 23634741
[TBL] [Abstract][Full Text] [Related]
29. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
[TBL] [Abstract][Full Text] [Related]
30. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
[TBL] [Abstract][Full Text] [Related]
31. An evidence based therapeutic approach to hereditary and acquired angioedema.
Bork K
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
[TBL] [Abstract][Full Text] [Related]
32. Current management options for hereditary angioedema.
Bork K
Curr Allergy Asthma Rep; 2012 Aug; 12(4):273-80. PubMed ID: 22729959
[TBL] [Abstract][Full Text] [Related]
33. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
[TBL] [Abstract][Full Text] [Related]
34. C1-esterase inhibitor (Cinryze
Gupta R; Balduzzi J; Davis-Lorton M
Immunotherapy; 2018 Jun; 10(8):635-642. PubMed ID: 29569504
[TBL] [Abstract][Full Text] [Related]
35. Kallikrein inhibitors for angioedema: the progress of preclinical and early phase studies.
Farkas H; Balla Z
Expert Opin Investig Drugs; 2024 Mar; 33(3):191-200. PubMed ID: 38366937
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in the management of hereditary angioedema.
Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic monoclonal antibodies with a focus on hereditary angioedema.
Zuraw BL; Maurer M; Sexton DJ; Cicardi M
Allergol Int; 2023 Jan; 72(1):54-62. PubMed ID: 35787344
[TBL] [Abstract][Full Text] [Related]
38. Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence.
Bork K; Machnig T; Wulff K; Witzke G; Prusty S; Hardt J
Orphanet J Rare Dis; 2020 Oct; 15(1):289. PubMed ID: 33059692
[TBL] [Abstract][Full Text] [Related]
39. Angioedema Without Wheals: Challenges in Laboratorial Diagnosis.
Grumach AS; Veronez CL; Csuka D; Farkas H
Front Immunol; 2021; 12():785736. PubMed ID: 34956216
[TBL] [Abstract][Full Text] [Related]
40. Update on therapeutic developments for hereditary angioedema.
Christiansen SC; Zuraw BL
Allergy Asthma Proc; 2009; 30(5):500-5. PubMed ID: 19843404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
